Oromia Regional Health Bureau, Addis Ababa, Ethiopia.
Department of Medical Laboratory Science, College of Medicine and Health Sciences, Arba Minch University, P.O. Box: 21, Arba Minch, Ethiopia.
Ann Clin Microbiol Antimicrob. 2018 Jul 3;17(1):30. doi: 10.1186/s12941-018-0283-8.
Curable disease tuberculosis is becoming incurable or difficult to treat due to drug resistance. Multi drug resistance tuberculosis is a major health problem for less developed countries. Development of drug resistance is mainly as result of man related factors and poor lifestyle. Identifying predictors of drug resistance and working on them is the important way of reducing the expansion in high burden countries. Ethiopia is one of TB, TB/HIV, and multi-drug resistant tuberculosis (MDR-TB) high burden country globally. This study was aimed to assess predictor of MDR-TB in southwest part of Ethiopia.
Unmatched case control study was conducted in case to control ratio of 1:1.2 in southwest part of Ethiopia. The cases were recruited from confirmed MDR-TB patient enrolled on second line treatment in Shenen Gibe Hospital (MDR-TB treatment center of the prefecture) and the controls were recruited from previously TB patients who cured or patient with smear negative at the end of treatment month during the study period in the same area. The data was collected by structured questionnaire by interview and logistic regression analyses were used to identify predictors of MDR-TB. Odds ratios with 95% CI were computed to determine the predictors.
From the total 132 participants about 45% of them were cases. None disclosed tuberculosis infected to relatives [AOR = 3.4, 95% CI (1.2-9.8)], insufficient instruction on how to take anti-TB drug [AOR = 4.7, 95% CI (1.4-14.6)], contact history with MDR-TB [AOR = 8.5, 95% CI (2.9-25.5)], interruption of first-line anti-TB treatment for at list 1 day [AOR = 7.9, 95% CI (2.5-24.9)], and having alcohol drinking habits [AOR = 5.1, 95% CI (1.4-18.7)] were identified predictors for MDR-TB infection in study area.
TB infection disclosure status, insufficient instruction on drug usage, contact history with MDR-TB, interruption of first-line anti-TB drugs, and alcohol drinking habits were identified predictor of MDR-TB case. Therefore, early detection and proper treatment of drug susceptible TB, strengthening directly observed treatment, short-course on daily bases, community involvement, and supporting the patient to intervene identified factors is paramount.
由于耐药性,可治愈的疾病结核病正变得难以治愈或难以治疗。耐多药结核病是欠发达国家的一个主要卫生问题。耐药性的发展主要是由于人为因素和不良生活方式造成的。确定耐药性的预测因素并加以解决是减少高负担国家耐药性扩大的重要途径。埃塞俄比亚是全球结核病、结核病/艾滋病、耐多药结核病(MDR-TB)负担较高的国家之一。本研究旨在评估埃塞俄比亚西南部地区 MDR-TB 的预测因素。
在埃塞俄比亚西南部,采用病例对照研究(病例与对照比例为 1:1.2)。病例组从在 Shenen Gibe 医院(该州的 MDR-TB 治疗中心)接受二线治疗的确诊 MDR-TB 患者中招募,对照组从同一地区研究期间在治疗结束时治愈或痰涂片阴性的既往结核病患者中招募。通过访谈用结构化问卷收集数据,并进行逻辑回归分析以确定 MDR-TB 的预测因素。使用 95%CI 计算比值比以确定预测因素。
在总共 132 名参与者中,约有 45%为病例。没有人向亲属透露结核病感染情况 [比值比(AOR)=3.4,95%置信区间(CI)(1.2-9.8)]、缺乏关于如何服用抗结核药物的指导 [AOR=4.7,95%CI(1.4-14.6)]、与 MDR-TB 的接触史 [AOR=8.5,95%CI(2.9-25.5)]、至少中断一线抗结核治疗 1 天 [AOR=7.9,95%CI(2.5-24.9)]和饮酒习惯 [AOR=5.1,95%CI(1.4-18.7)]被确定为该研究地区 MDR-TB 感染的预测因素。
结核病感染披露状况、药物使用指导不足、与 MDR-TB 的接触史、一线抗结核药物中断和饮酒习惯是 MDR-TB 病例的预测因素。因此,早期发现和适当治疗药物敏感结核病,加强直接观察治疗、基于每日的短程治疗、社区参与和支持患者干预确定因素至关重要。